Bright Minds Biosciences Inc (DRUG) — Cash Flow Quality Index

Latest as of December 2024: -30.12x

Bright Minds Biosciences Inc (DRUG) has a Cash Flow Quality Index of -30.12x as of December 2024. Operating cash flow of $-1.49 Million is below net income of $49.61K, suggesting accrual-heavy earnings not yet converted to cash. Also explore DRUG total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

-30.12x

Operating CF / Net Income

Operating Cash Flow

$-1.49 Million

USD

Net Income

$49.61K

USD

Data as of

Dec 2024

Most recent filing

Annual Cash Flow Quality Index for Bright Minds Biosciences Inc (None–None)

Year-by-year earnings quality comparison for Bright Minds Biosciences Inc. For live market cap and the full company financial profile, see market value of Bright Minds Biosciences Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.